Günalp Uzun: DGTI 2026 New Insights in Platelet Immunology and Hemostasis
Günalp Uzun, Clinician Scientist at Universitätsklinikum Tübingen, shared a post on LinkedIn:
“Looking forward to DGTI2026 in Stuttgart or Tübingen!
My team will be presenting 3 oral presentations on our latest findings in platelet immunology and hemostasis.
Omid Haghighi Glycoprotein-specific antibodies differentially induce cell death, alter autophagy and proplatelet formation in human megakaryocytes in vitro
September 23 at 14:10 to 14:20
Sergio Origel Romero Dynamic range analysis of antiPF4 or heparin IgG ELISA enables improved risk stratification in heparin induced thrombocytopenia
September 25 at 11:20 to 11:30
Qilu Lyu Different signaling pathways involved in ITP antibody-induced platelet desialylation
September 25 at 11:30 to 11:40
Looking forward to discussions with colleagues and learning from the latest research in the field.
23 to 25. September 2026 Stuttgart
See you there!”
Stay updated with Hemostasis Today.
-
Aug 29, 2026, 15:09Abdulbari Mohammed: The Basics of Antiphospholipid Syndrome
-
Aug 29, 2026, 15:06Laurent Arnaud: Rare SLE Manifestations Demand More Than Rare Attention – Insights from The Lancet Rheumatology
-
Aug 29, 2026, 14:55Marco Vitolo: The Changing Landscape of Sex Differences in AF-Related Stroke
-
Aug 29, 2026, 14:54Hiteshi K.C. Chauhan: Should Patients with AF and Intermediate Stroke Risk Receive Anticoagulation?
-
Aug 29, 2026, 14:39C. Michael Gibson: SINGLE-AF Trial Supports DOAC Use in Intermediate-Risk Atrial Fibrillation
-
Aug 29, 2026, 14:07Vincent Rizzo: Beta Blocker Choice May Impact Portal Vein Thrombosis and Survival in Cirrhosis
-
Aug 29, 2026, 13:59Eleftheria Hatzimichael: ASH 2026 Guidelines for Primary ITP What Is Changing
-
Aug 29, 2026, 11:03Richard Davis: Navigating Acute PE – ESC vs. the New AHA/ACC Guidelines
-
Aug 29, 2026, 10:57Bartosz Hudzik: First RCT Evidence for a Long-Standing Guideline Gray Zone